Good results reported with emergency-use and compassionate-use cases ...

Edwards today presented new data at New York Valves 2026 supporting its transcatheter aortic valve replacement (TAVR) ...

New research simultaneously published today in JSCAI and presented at New York Valves 2026 reported favorable one-year ...

TCT 904: Case of trans-catheter aortic valve-in-valve-in-valve implantation with valve "fracking" and subsequent coronary obstruction Receive the the latest news, research, and presentations from ...

Real-world mortality complicates reassurances in trial results ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

In the United States, cardiovascular health is especially important. Heart disease is the leading cause of death in the U.S., and as many as 1.5 million people have been diagnosed with aortic stenosis ...

Cedars-Sinai investigators are experienced in the use of transcatheter aortic valve replacement (TAVR) with balloon-expandable valves. They now show that redo TAVR procedures are both safe and ...

New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a strategy of early intervention with transcatheter aortic valve replacement ...

In December, Edwards Lifesciences persuaded CMS to publish an updated tracking sheet for TAVR national coverage analysis, causing the agency to reconsider its previous stance on covering transcatheter ...

Transcatheter aortic valve replacement (TAVR) is a procedure that can treat narrowing of the aortic valve in the heart. It involves an expandable replacement valve that helps improve blood flow. A ...

PLYMOUTH MEETING, Pa. (WPVI) -- The TAVR procedure has revolutionized a challenging task in heart care: fixing stiff valves. And it has made the process much easier for patients, getting them back to ...